Results 1 to 10 of about 634,572 (253)

A comparison of the binding sites of antibodies and single-domain antibodies [PDF]

open access: yesFrontiers in Immunology, 2023
Antibodies are the largest class of biotherapeutics. However, in recent years, single-domain antibodies have gained traction due to their smaller size and comparable binding affinity.
Gemma L. Gordon   +5 more
doaj   +5 more sources

Species-Dependent Structural Variations in Single-Domain Antibodies [PDF]

open access: yesAntibodies
Background/Objectives: Single-domain antibodies (sdAbs) are derived from camelid heavy-chain antibodies (HCAb). Their small size, high stability, and ease of production, among other properties, makes them highly valuable in biomedical research and ...
Marta Baselga   +3 more
doaj   +2 more sources

Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR

open access: yesPharmaceutics, 2020
Passive immunotherapy, i.e., treatment with therapeutic antibodies, has been increasingly used over the last decade in several diseases such as cancers or inflammation.
Elodie Pothin   +2 more
doaj   +3 more sources

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses [PDF]

open access: yesNature Communications
Influenza B viruses are antigenically diverse and contribute significantly to the annual influenza burden. Here we report influenza B virus neutralizing single-domain antibodies that target highly conserved regions of the hemagglutinin and neuraminidase.
Arne Matthys   +9 more
doaj   +2 more sources

An Inside Job: Applications of Intracellular Single Domain Antibodies

open access: yesBiomolecules, 2020
Sera of camelid species contain a special kind of antibody that consists only of heavy chains. The variable antigen binding domain of these heavy chain antibodies can be expressed as a separate entity, called a single domain antibody that is ...
Eline Soetens   +2 more
doaj   +3 more sources

Inhibition of tau neuronal internalization using anti-tau single domain antibodies [PDF]

open access: yesNature Communications
In Alzheimer’s disease, tau pathology spreads across brain regions as the disease progresses. Intracellular tau can be released and taken up by nearby neurons.
Clément Danis   +12 more
doaj   +2 more sources

Single-domain antibodies as therapeutics for solid tumor treatment [PDF]

open access: yesActa Pharmaceutica Sinica B
Single-domain antibodies (sdAbs), initially identified in camelids or sharks and commonly referred to as nanobodies or VNARs, have emerged as a promising alternative to conventional therapeutic antibodies.
Mingkai Wang, Tianlei Ying, Yanling Wu
doaj   +2 more sources

Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer [PDF]

open access: yesEJNMMI Radiopharmacy and Chemistry
Background Radiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) has shown to be a promising strategy in the development of sdAb-based PET tracers. While automation of the prosthetic group (PG) [18F]SFB
Herlinde Dierick   +11 more
doaj   +2 more sources

Single domain antibodies from camelids in the treatment of microbial infections [PDF]

open access: yesFrontiers in Immunology
Infectious diseases continue to pose significant global health challenges. In addition to the enduring burdens of ailments like malaria and HIV, the emergence of nosocomial outbreaks driven by antibiotic-resistant pathogens underscores the ongoing ...
Henri De Greve   +3 more
doaj   +2 more sources

Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein. [PDF]

open access: yesPLoS ONE, 2016
Single-domain antibodies derived from the unique New Antigen Receptor found in sharks have numerous potential applications, ranging from diagnostic reagents to therapeutics.
George P Anderson   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy